McEvoy Ashley 4

4 · JOHNSON & JOHNSON · Filed Feb 15, 2023

Form 4

Period: 2023-02-13

EVP, WW Chair, Medical Devices

Transactions

Award
Common Stock
2023-02-13+17,994→ 61,982.955 total
Tax Payment
Common Stock
2023-02-13$162.01/sh−7,158$1,159,668→ 54,824.955 total
Award
Employee Stock Options (Right to Buy)
2023-02-13+61,295→ 61,295 total
Exercise: $162.75Exp: 2033-02-13→ Common Stock (61,295 underlying)
Award
Restricted Share Units
2023-02-13+3,704→ 3,704 total
→ Common Stock (3,704 underlying)

Holdings

Footnotes (6)

[F1]Represents Common Stock received upon the satisfaction of performance and time-based criteria for Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 10, 2020.
[F2]Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2023).
[F3]Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2023).
[F4]Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.
[F5]Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock.
[F6]The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file